Results
1 -
9 of
9
(Click
here to explore results)
Neglected Diseases and Drug Discovery, Chapter 12 Managing the HIV Epidemic in the Developing World – Progress and Challenges . Elna van der Ryst, Michael J Palmer, Cloete van Vuuren
, 2012
, Pages 322-365
Drug Design Strategies: Quantitative Approaches, Chapter 5 Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs . Alexander A. Alex, David S. Millan
, 2012
, Pages 108-163
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 6 HIV Integrase Inhibitors . Brian A. Johns, Takashi Kawasuji, Emile J. Velthuisen
, 2013
, Pages 149-188
Green Chemistry Strategies for Drug Discovery, Chapter 13 The Business Case for Green Chemistry in Drug Discovery . Joseph M. D. Fortunak, Martins O. Emeje, Harriet Kammendi, Ermias L. Tilahun, Xiang S. Wang
, 2015
, Pages 280-313
Synthetic Methods in Drug Discovery: Volume 1, Chapter 8 C–H Activation Approaches to Molecules . Elizabeth M. Beck, Antonia F. Stepan, Damien Webb
, 2016
, Volume 1
, Pages 274-383
Structural Virology, Chapter 15 Development of Anti-HIV Drugs . Roxana M. Coman, Robert McKenna
, 2011
, Pages 291-318
Synthetic Methods in Drug Discovery: Volume 2, Subject Index
, 2016
, Volume 2
, Pages 505-517
Synthetic Methods in Drug Discovery: Volume 1, Subject Index
, 2016
, Volume 1
, Pages 443-455
Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets . Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27